	Multipathway pharmacological interventions targeting liver-derived immune resistance in colorectal cancer liver metastasis. Front Immunol Chen M, Qin S, Zhan Y, Wang Q. PMID: 42857020 [PubMed - indexed for MEDLINE]
	Prediction of treatment response and survival in patients with advanced hepatocellular carcinoma receiving sorafenib: pretreatment prognostic scores. J Egypt Natl Canc Inst Hatem A, Nabeel MM, K Darweesh S, Zayed R, Omar Abdelaziz A, Ibrahim Shousha H, Hosni Abdelmaksoud A, Medhat E, Mahmoud Elbaz T, Ali Rashwan M, Ramadan A, Lithy R. PMID: 42853364 [PubMed - indexed for MEDLINE]
	Real-world outcomes of atezolizumab-bevacizumab and durvalumab-tremelimumab in unresectable hepatocellular carcinoma: a systematic review with covariate-adjusted meta-regression and exploratory machine learning analysis. Front Immunol Lee J, Tak KY, Cho HS, Lee J, Yang K, Sung PS, Jang JW, Han JW. PMID: 42851630 [PubMed - indexed for MEDLINE]
	Transarterial Radioembolization Versus Chemoembolization for Unresectable Large Single Hepatocellular Carcinoma. Korean J Radiol Lee M, Kim M, Kim J, Kim DH, Chung JW, Kim HC. PMID: 42849888 [PubMed - indexed for MEDLINE]
	Association of 5-hydroxytryptamine 3 receptor antagonists with prognosis in patients with advanced hepatocellular carcinoma: A propensity score-matched study. PLoS One Zhang X, Wang X, Li N, Han Q, Liu Z. PMID: 42848747 [PubMed - indexed for MEDLINE]
	Cancer-associated fibroblasts in therapeutic resistance of hepatocellular carcinoma: evidence, mechanisms, and translational implications. Med Oncol Huang T, Li Q, Yu Z, Wu Z, Cheng H, Zhang X, Yang L, Wang S. PMID: 42848120 [PubMed - indexed for MEDLINE]
	Unlocking Prognostic Potential: Serum Uric Acid and Prothrombin Time as Predictors of HCC Recurrence. Clin Lab Xiao Y, Lin Q, Yang K, Su G. PMID: 42847944 [PubMed - indexed for MEDLINE]
	Insulin Resistance and Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients Under Antiviral Therapy. J Korean Med Sci Sinn DH, Kim KA, Lee JI, Gwak GY. PMID: 42843350 [PubMed - indexed for MEDLINE]
	Baseline PET/CT Radiomics and Clinical Indicators for Pretreatment Response Prediction in Unresectable Hepatocellular Carcinoma: Model Development and Internal Validation. Technol Cancer Res Treat Cheng Y, Chen C, Tang Y, Xu Y, Huang J, Mo Q, Xu F, Lin D. PMID: 42842349 [PubMed - indexed for MEDLINE]
	Baseline low-level viremia in HBV-related hepatocellular carcinoma: prognostic significance, risk stratification, and clinical implications. Front Immunol Ma H, Yu L, Liu X, Yan H, Xie Y, Shang Z, Huo G, Shi W, Zhang Z, Yang Z. PMID: 42840955 [PubMed - indexed for MEDLINE]
	The acidic tumor microenvironment in hepatocellular carcinoma: a barrier to adoptive cellular immunotherapy. Front Immunol Xiong J, Mou G, Ze T, Li X, Zhao H. PMID: 42840603 [PubMed - indexed for MEDLINE]
	Decoding the spatial logic of immune evasion in hepatocellular carcinoma: from single-cell profiling to spatial omics. Front Immunol Xi N, Gao S, Dai C. PMID: 42840587 [PubMed - indexed for MEDLINE]
	A novel clinical FIT model predicts prognosis of unresectable hepatocellular carcinoma treated with TACE combined with lenvatinib and PD-1 inhibitors therapy. Front Immunol Liao M, Wang Z, Wang X, Ai X, Song L, Song Y, Qin W, Wang K, Zhou Y, Liu F, Rao H. PMID: 42840156 [PubMed - indexed for MEDLINE]
	Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores. Liver Int Stefanini B, Rimassa L, Iavarone M, Cabibbo G, Marra F, Vivaldi C, Dalbeni A, Ponziani FR, Palloni A, Lonardi S, Lani L, Federico P, Svegliati-Baroni G, Pressiani T, Ielasi L, Mazzarelli C, De Lorenzo S, Sacco R, Bruccoleri M, Celsa C, Mastro A, Masi G, Auriemma A, Stella L, Toniutto P, Villani R, Deiana C, Ascari S, Marseglia M, Granito A, Piscaglia F, Tovoli F, ARTE Study Group. PMID: 42839680 [PubMed - indexed for MEDLINE]
	ITO-based multi-band metasurface absorber for early detection of hepatic cancer through deep learning. Opt Express Farooq U, Asif Khan H, Murtaza F, Alathbah M, Yang L, Liu N. PMID: 42839429 [PubMed - indexed for MEDLINE]
	Highly sensitive detection of exosomal miR-122 with CRISPR-Dx for precise HCC diagnosis. Anal Chim Acta Xie C, Lv H, Wang Y, Abdukayum A, Li X, Wu P. PMID: 42838687 [PubMed - indexed for MEDLINE]
	Perfusion beyond Margin in Hepatocellular Carcinoma: A Contrast-enhanced US Feature Related to Tumor Invasiveness and Prognosis. Radiology Ding W, Ji R, Pang C, Li J, Liu F, Yu J, Liang P. PMID: 42836755 [PubMed - indexed for MEDLINE]
	Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. Immun Inflamm Dis Kjær LK, Theile S, Madsen K, Johansen JS, Holmström MO, Andersen MH, Chen IM. PMID: 42836590 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma in the Eastern World: Screening, Diagnosis, Staging and Treatment. Curr Pharm Des Wu TH, Cheng CH, Wang YC, Hung HC, Lee JC, Lai Y, Wu TJ, Chou HS, Lee CF, Lee WC, Chan KM. PMID: 42836499 [PubMed - indexed for MEDLINE]
	Polymeric Nanomedicines for siRNA Delivery in Hepatocellular Carcinoma: Emerging Therapeutic Strategies, Combination Approaches, and Translational Perspectives. Int J Nanomedicine Thalij KM, You HW, Habeeb M, Ratchagar JV, Khot VS, Gorde PL. PMID: 42836161 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77760

Page 1 of 3888



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy